SkyDance Vascular Selected to Exhibit OspreyIV Catheter Systems at Vizient Innovative Technology Exchange
OspreyIV’s proprietary through-the-needle technology addresses key challenges in catheter protection, vessel
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.
OspreyIV’s proprietary through-the-needle technology addresses key challenges in catheter protection, vessel preservation and needlestick safety
DELRAY BEACH FL, FL, UNITED STATES, August 11, 2026 /EINPresswire.com/ — SkyDance Vascular has been selected to exhibit its Osprey Midline Closed IV Catheter System at the Vizient® Innovative Technology Exchange. Vizient, the nation’s largest provider-driven healthcare performance improvement company, will hold the Exchange Sept. 24 in Las Vegas.
The annual Innovative Technology Exchange offers selected suppliers the unique opportunity to demonstrate their product or service to supply chain and clinical leaders from Vizient’s hospital clients and subject matter experts who serve on its supply councils. Each product or service will showcase how it improves clinical outcomes, enhances safety or drives incremental improvements to healthcare delivery or business models.
The Osprey Midline Closed IV Catheter System is the only available vascular access device platform to deploy a vascular catheter through a needle. Its proprietary design combines Skin Avoidance Technology, a Bevel-Only Insertion technique, Passive Needle Retraction and Contoured Directional Flow. Together, these features are designed to help protect the catheter during insertion, reduce the opportunity for insertion-related contamination, support successful catheter placement, preserve the vessel and provide an unmatched level of protection against needlestick injury.
By uniquely addressing risks associated with catheter contamination, vessel trauma and catheter failure, SkyDance Vascular aims to help clinicians extend dwell times, improve therapy completion and enhance the patient experience while maintaining an intuitive clinical workflow.
“Being selected for the Vizient Innovative Technology Exchange is an important opportunity to place Osprey Midline directly in the hands of the clinical and supply-chain leaders who understand the challenges of peripheral vascular access,” said Bill Bold, chief executive officer of SkyDance Vascular. “Our through-the-needle platform was designed to address several persistent sources of risk in a single, intuitive system. We look forward to demonstrating how OspreyIV can help protect the catheter, preserve the vessel and support better outcomes for patients and providers.”
“The Innovative Technology Exchange provides a distinctive platform for healthcare providers to engage with products and services that may influence the healthcare landscape and enhance clinical care or organizational business models,” said Kelly Flaharty, associate vice president of contract operations, Vizient. “We are pleased to extend an invitation to SkyDance Vascular to participate in the Exchange.”
The annual Innovative Technology Exchange is part of Vizient’s Innovative Technology Program, which includes product review of supplier-submitted technologies by provider-led councils. Since 2003, Vizient has reviewed over 1,700 product submissions as part of its Innovative Technology Program.
About SkyDance Vascular
Founded in 2017, SkyDance Vascular has reimagined the peripheral intravenous catheter with its OspreyIV product portfolio. The company’s proprietary through-the-needle catheter deployment technology is designed to protect the catheter during insertion, improve insertion success, preserve vessels and enhance safety. The OspreyIV portfolio includes FDA-cleared peripheral IV, closed peripheral IV and midline closed IV catheter systems. SkyDance Vascular is led by a team of experienced executives, clinicians, engineers and regulatory professionals with a history of innovation in vascular access. For more information, visit www.skydancevascular.com or contact Mike Anstett at mike.anstett@skydancevascular.com.
Bill Bold
SkyDance Vascular
+1 561-573-5360
email us here
Visit us on social media:
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Media gallery
